Core Laboratories Inc.

American service Provider

CLB NYSE ISIN NL0000200384 SEC CIK 1958086 LEI 724500MDYY5VBSAF5W50
Follow Core Laboratories Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $132.1M −1.8% vs same quarter last year
Net income $5.4M −61.8% vs same quarter last year
EPS, diluted $0.12 −60% vs same quarter last year
Operating cash flow $5M −41.6% vs same quarter last year
Revenue by quarter
$129.2M
$123.6M
$130.2M
$134.5M
$138.3M
$121.8M
$124.6M
$132.1M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing